<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-37242" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Clark's Rule</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Delgado</surname>
            <given-names>Benjamin J.</given-names>
          </name>
          <aff>Ross University School of Medicine</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Safadi</surname>
            <given-names>Anthony O.</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Bajaj</surname>
            <given-names>Tushar</given-names>
          </name>
          <aff>University of Chicago</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Benjamin Delgado declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Anthony Safadi declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Tushar Bajaj declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>30</day>
          <month>7</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-37242.s1" sec-type="Definition/Introduction">
        <title>Definition/Introduction</title>
        <p content-type="pubmed-excerpt">Clark's rule is an equation used to calculate pediatric medication dosage based on the known weight of a patient and a known adult dose of medication to&#x000a0;be used. Clark's rule equation is defined as the weight of the patient in pounds divided by the average standard weight of&#x000a0;150 pounds (68 kg) multiplied by the adult dose of a drug to obtain&#x000a0;the pediatric medication dose, as is demonstrated below:&#x000a0; &#x000a0; &#x000a0;&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>
<bold>(Weight* divided by&#x000a0;150 lbs.) x&#x000a0;<bold>Adult Dose**</bold>&#x000a0;= Pediatric Dosage</bold>
</p>
          </list-item>
          <list-item>
            <p>
<bold>(Weight*** divided by 68 kg) x&#x000a0;<bold>Adult Dose**</bold>&#x000a0;= Pediatric Dosage</bold>
</p>
          </list-item>
        </list>
        <p>*Weight of pediatric patient in pounds (lbs.)</p>
        <p>**Adult dose is the recommended dosage for adult medication use</p>
        <p>***Weight of pediatric patient in kilograms (kg)</p>
        <p>Clark's rule is a known pediatric medication dosing rule&#x000a0;described in the medical literature that utilizes the patient's weight to&#x000a0;calculate medication dosage. Other equations that utilize pediatric weight to calculate medication dosing include Salisbury's rule, Penna's rule, and the Body Surface Area rule. Other methods besides Clark's rule that utilize pediatric age to calculate radiopharmaceutical&#x000a0;medication&#x000a0;dosages used in nuclear imaging include Young's rule, Webster's rule, and Fried's rule.<xref ref-type="bibr" rid="article-37242.r1">[1]</xref><xref ref-type="bibr" rid="article-37242.r2">[2]</xref></p>
      </sec>
      <sec id="article-37242.s2" sec-type="Issues of Concern">
        <title>Issues of Concern</title>
        <p>
<bold>Pediatric Obesity and Medication Dosing</bold>
</p>
        <p>Data from 2011 to 2014 showed the prevalence&#x000a0;of obesity among children and adolescents aged 2 to 19&#x000a0;years to be 17% in the United States and continues to increase.<xref ref-type="bibr" rid="article-37242.r3">[3]</xref>&#x000a0;In addition to the known&#x000a0;numerous health complications and the development of comorbidities associated with pediatric obesity, this epidemic has created challenges to weight-based medication dosing because of the&#x000a0;pharmacokinetic&#x000a0;changes associated with obesity.</p>
        <p>For medication distribution,&#x000a0;excess adipose tissue in obese pediatric patients has been described as affecting a medication's volume distribution (the amount of drug in the body compared to plasma concentration). Lipophilic medications&#x000a0;are&#x000a0;more likely to have&#x000a0;higher&#x000a0;volume distribution&#x000a0;into&#x000a0;adipose tissue&#x000a0;when compared to&#x000a0;normal-weight&#x000a0;pediatric patients. In contrast, hydrophilic drugs may have increased or decreased volume distributions, altering the medication loading dose.<xref ref-type="bibr" rid="article-37242.r4">[4]</xref>&#x000a0;</p>
        <p>Due to the alterations in medication loading doses, obese pediatric patients may be at risk for either medication toxicity or sub-therapeutic medication therapy. Studies have described ideal body weight for calculating a hydrophilic medication loading dose, total body weight for a lipophilic medications loading dose, and adjusted body weight for a partially&#x000a0;lipophilic medication loading dose.<xref ref-type="bibr" rid="article-37242.r5">[5]</xref><xref ref-type="bibr" rid="article-37242.r6">[6]</xref>&#x000a0;</p>
        <p>Pediatric obesity's effects&#x000a0;on pharmacokinetic changes in medication absorption, metabolism, and excretion remain an area in need of further research.<xref ref-type="bibr" rid="article-37242.r4">[4]</xref></p>
      </sec>
      <sec id="article-37242.s3" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>Medication dosing for pediatric patients is described to use either the following methods for&#x000a0;medication dosing: age-based dosing, allometric scaling, body surface area-based dosing, and weight-based dosing;&#x000a0;no single approach is superior to the other and varies based on a medication's chemical properties and the age of the patient.<xref ref-type="bibr" rid="article-37242.r7">[7]</xref>&#x000a0;Weight-based dosing is the most commonly used method for calculating recommended&#x000a0;medication doses in pediatric clinical practice.<xref ref-type="bibr" rid="article-37242.r8">[8]</xref></p>
        <p>Some have thought that adult medication dosages are universally applied to pediatric patients when in fact, this is a misconception. Pediatric patient pharmacokinetics and pharmacodynamics vary&#x000a0;based on age, body weight, body surface area, and developmental growth and function of various organ systems compared to adults.<xref ref-type="bibr" rid="article-37242.r7">[7]</xref>&#x000a0;</p>
        <p>The absence of deliberate practice in correct pediatric medication dosing can have potentially detrimental effects, such as exposing the patient to suboptimal medication dosages and severe systemic toxicity, which may even result in fatalities.</p>
      </sec>
      <sec id="article-37242.s4" sec-type="Nursing, Allied Health, and Interprofessional Team Interventions">
        <title>Nursing, Allied Health, and Interprofessional Team Interventions</title>
        <p>Nursing and pharmacy should be familiar with Clark's rule since they will prepare, dispense, and administer&#x000a0;medications to infants and children. This way, they can add another layer of safety&#x000a0;when administering drugs&#x000a0;to children and reach out to the prescribing or ordering clinician if they suspect an incorrect dose when using Clark's rule. This interprofessional system of checks and balances can optimize patient outcomes. [Level 5]</p>
      </sec>
      <sec id="article-37242.s5">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=37242&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=37242">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/37242/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=37242">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-37242.s6">
        <title>References</title>
        <ref id="article-37242.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Elias</surname>
                <given-names>GP</given-names>
              </name>
              <name>
                <surname>Antoniali</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Mariano</surname>
                <given-names>RC</given-names>
              </name>
            </person-group>
            <article-title>Comparative study of rules employed for calculation of pediatric drug dosage.</article-title>
            <source>J Appl Oral Sci</source>
            <year>2005</year>
            <month>Jun</month>
            <volume>13</volume>
            <issue>2</issue>
            <fpage>114</fpage>
            <page-range>114-9</page-range>
            <pub-id pub-id-type="pmid">20924533</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37242.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Accorsi</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Karp</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Surti</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Improved dose regimen in pediatric PET.</article-title>
            <source>J Nucl Med</source>
            <year>2010</year>
            <month>Feb</month>
            <volume>51</volume>
            <issue>2</issue>
            <fpage>293</fpage>
            <page-range>293-300</page-range>
            <pub-id pub-id-type="pmid">20080887</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37242.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ogden</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Carroll</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Lawman</surname>
                <given-names>HG</given-names>
              </name>
              <name>
                <surname>Fryar</surname>
                <given-names>CD</given-names>
              </name>
              <name>
                <surname>Kruszon-Moran</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Kit</surname>
                <given-names>BK</given-names>
              </name>
              <name>
                <surname>Flegal</surname>
                <given-names>KM</given-names>
              </name>
            </person-group>
            <article-title>Trends in Obesity Prevalence Among Children and Adolescents in the United States, 1988-1994 Through 2013-2014.</article-title>
            <source>JAMA</source>
            <year>2016</year>
            <month>Jun</month>
            <day>07</day>
            <volume>315</volume>
            <issue>21</issue>
            <fpage>2292</fpage>
            <page-range>2292-9</page-range>
            <pub-id pub-id-type="pmid">27272581</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37242.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kendrick</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Carr</surname>
                <given-names>RR</given-names>
              </name>
              <name>
                <surname>Ensom</surname>
                <given-names>MH</given-names>
              </name>
            </person-group>
            <article-title>Pharmacokinetics and drug dosing in obese children.</article-title>
            <source>J Pediatr Pharmacol Ther</source>
            <year>2010</year>
            <month>Apr</month>
            <volume>15</volume>
            <issue>2</issue>
            <fpage>94</fpage>
            <page-range>94-109</page-range>
            <pub-id pub-id-type="pmid">22477800</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37242.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kendrick</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Carr</surname>
                <given-names>RR</given-names>
              </name>
              <name>
                <surname>Ensom</surname>
                <given-names>MH</given-names>
              </name>
            </person-group>
            <article-title>Pediatric Obesity: Pharmacokinetics and Implications for Drug Dosing.</article-title>
            <source>Clin Ther</source>
            <year>2015</year>
            <month>Sep</month>
            <day>01</day>
            <volume>37</volume>
            <issue>9</issue>
            <fpage>1897</fpage>
            <page-range>1897-923</page-range>
            <pub-id pub-id-type="pmid">26361823</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37242.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Matson</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Horton</surname>
                <given-names>ER</given-names>
              </name>
              <name>
                <surname>Capino</surname>
                <given-names>AC</given-names>
              </name>
              <collab>Advocacy Committee for the Pediatric Pharmacy Advocacy Group</collab>
            </person-group>
            <article-title>Medication Dosage in Overweight and Obese Children.</article-title>
            <source>J Pediatr Pharmacol Ther</source>
            <year>2017</year>
            <season>Jan-Feb</season>
            <volume>22</volume>
            <issue>1</issue>
            <fpage>81</fpage>
            <page-range>81-83</page-range>
            <pub-id pub-id-type="pmid">28337087</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37242.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bartelink</surname>
                <given-names>IH</given-names>
              </name>
              <name>
                <surname>Rademaker</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Schobben</surname>
                <given-names>AF</given-names>
              </name>
              <name>
                <surname>van den Anker</surname>
                <given-names>JN</given-names>
              </name>
            </person-group>
            <article-title>Guidelines on paediatric dosing on the basis of developmental physiology and pharmacokinetic considerations.</article-title>
            <source>Clin Pharmacokinet</source>
            <year>2006</year>
            <volume>45</volume>
            <issue>11</issue>
            <fpage>1077</fpage>
            <page-range>1077-97</page-range>
            <pub-id pub-id-type="pmid">17048973</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37242.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pan</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Zhu</surname>
                <given-names>LL</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Xia</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Zhou</surname>
                <given-names>Q</given-names>
              </name>
            </person-group>
            <article-title>Weight-based dosing in medication use: what should we know?</article-title>
            <source>Patient Prefer Adherence</source>
            <year>2016</year>
            <volume>10</volume>
            <fpage>549</fpage>
            <page-range>549-60</page-range>
            <pub-id pub-id-type="pmid">27110105</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
